|
|||
2011-02-03 16:30:00 CET 2011-02-03 16:30:42 CET REGULATED INFORMATION Biotie Therapies - Major shareholder announcementsNotification according to Chapter 2, Section 10 of the Finnish Securities Market ActBIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 3 February 2011 at 5.30 p.m. Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act Biotie Therapies Corp. ("Company" or "Biotie") has gained knowledge of the notifications regarding changes in holdings in accordance with Chapter 2, Section 9 of the Finnish Securities Markets Act, described below. The notifications received by the Company concern the changes in holdings of Suomen itsenäisyyden juhlarahasto ("Sitra"). The mentioned change in holdings is related to the Combination Agreement entered into on 10 January 2011 among the Company, Synosia Therapeutics Holding AG ("Synosia") as well as Synosia's shareholders and warrant holders, described in more detail in a stock exchange release issued on 11 January 2011. As described in detail in Biotie's stock exchange release issued on 2 February 2011, Biotie's Extraordinary General Meeting has on 1 February 2011 passed resolutions necessary for the completion of the transaction and the other prerequisites for the completion of the transaction have been fulfilled, and the Company has issued 161,448,371 shares to the shareholders and warrant holders of Synosia as consideration for the entire issued share capital and outstanding warrants of Synosia (the "Transaction"). In connection with the Transaction, the Company issued 14,912,155 new shares to Synosia to be held in treasury and used to satisfy future potential exercise of Synosia's options. The new shares have been registered on 3 February 2011. As a consequence of the Transaction Sitra's holding of shares and votes in the Company decreased below 5 % as follows: Name Number of Number of Number of Share of Share of shares voting shares and share voting before rights voting capital rights after Transaction before rights after after Transaction Transaction Transaction Transaction (%) (%) Suomen 13,585,350 13,585,350 13,585,350 3.86 4.21 itsenäisyyden juhlarahasto The number of voting rights and percentages presented above are calculated based on number of shares and voting rights obtained upon completion of the Transaction taking into account the treasury shares held by the Company on the date of the notification. On the date hereof, the registered number of shares in Biotie Therapies Corp. is 352,364,457. Of these shares 29,659,239 are held by the Company or its group companies and the number of outstanding registered shares and voting rights attached to such shares amounts thus to 322,705,218. Turku, 3 February 2011 Biotie Therapies Corp. Timo Veromaa President and CEO For further information, please contact: Virve Nurmi, Biotie Therapies Corp. tel. +358 2 274 8900 e-mail:virve.nurmi@biotie.com DISTRIBUTION NASDAQ OMX Helsinki Ltd Main Media www.biotie.com [HUG#1485220] |
|||
|